{"id":259226,"date":"2019-10-07T07:00:05","date_gmt":"2019-10-07T10:00:05","guid":{"rendered":"https:\/\/anba.com.br\/?p=259226"},"modified":"2019-10-04T18:37:24","modified_gmt":"2019-10-04T21:37:24","slug":"saudi-pharma-market-the-topic-of-seminar","status":"publish","type":"post","link":"https:\/\/anba.com.br\/en\/saudi-pharma-market-the-topic-of-seminar\/","title":{"rendered":"Saudi pharma market the topic of seminar"},"content":{"rendered":"<p>S\u00e3o Paulo \u2013 The 1<sup>st<\/sup> Brazil-Saudi Arabia Pharma Seminar is taking place next Tuesday (8) at the <a href=\"http:\/\/www.ccab.org.br\/en\/home\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Arab Brazilian Chamber of Commerce<\/strong><\/a> in S\u00e3o Paulo. Brazilian and Saudi business leaders will discuss pharma market opportunities and challenges in the Arab country. The seminar is hosted by the Saudi Food and Drug Authority (<a href=\"https:\/\/www.sfda.gov.sa\/en\" target=\"_blank\" rel=\"noopener noreferrer\">SFDA<\/a>), the Saudi Pharma <a href=\"https:\/\/www.ic.gov.sa\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">Industrial Clusters<\/a>, the Brazilian National Health Surveillance Agency(<a href=\"http:\/\/portal.anvisa.gov.br\/\" target=\"_blank\" rel=\"noopener noreferrer\">Anvisa<\/a>), the Brazilian Pharma Inputs Association (<a href=\"http:\/\/abiquifi.org.br\/\" target=\"_blank\" rel=\"noopener noreferrer\">Abiquifi<\/a>) and the Pharma Products Industry Union (<a href=\"https:\/\/sindusfarma.org.br\/\" target=\"_blank\" rel=\"noopener noreferrer\">Sindusfarma<\/a>), with support from the Arab Chamber.<\/p>\n<p>The Saudi pharmaceuticals market is currently worth SAR 30 billion, and gets 5% bigger each year, with opportunities available in generic drugs and vaccines.<\/p>\n<p>The seminar will feature Arab Chamber secretary-general Tamer Mansour; Sindusfarma markets director Bruno abreu; Abiquifi chairman Sergio Frangioni; Saudi Pharma Industrial Clusters vice president Raed Al-Swayed; SFDA chief pharmacist for regulatory affairs Bandar Al Hammad; Saudi Pharma Industrial Clusters strategy and investment promotion director Adalberto Netto; and a delegate from Anvisa.<\/p>\n<p>\u201cWhen it comes to healthcare, the Saudi government makes purchases and invests in goods and services. It\u2019s a big market where 70% of products are still imports. We are coming to Brazil precisely to present to our Brazilian partners the opportunities in investment, intelligence and market information,\u201d Adalberto Netto told ANBA.<\/p>\n<p>Saudi Industrial Clusters is a Saudi government program. The Brazilian-born Netto is a former <a href=\"https:\/\/anba.com.br\/en\/investment-latin-america-shifting\/\" target=\"_blank\" rel=\"noopener noreferrer\">Paran\u00e1 Development Agency<\/a> chair. Now based in Riyadh, the Saudi capital, he coordinates the program\u2019s international investment promotion strategy, which is working with ten different industries. Saudi Arabia\u2019s Vision 2030 plan should see the Health Ministry invest USD 71 billion through 2020.<\/p>\n<p><strong>Investment and exports<\/strong><\/p>\n<p>The Brazil-Saudi Arabia Pharma Seminar will include a roundtable discussion. Afterwards, companies will get one-on-one access to clear up questions. \u201cSaudi Arabia\u2019s per capita investment in the industry is bigger than Brazil\u2019s. The enterprises will learn how they can access the markets of Saudi Arabia and its neighboring countries,\u201d he explained \u2013 there\u2019s also a possibility of finding a market in <a href=\"https:\/\/www.oic-oci.org\/home\/?lan=en\" target=\"_blank\" rel=\"noopener noreferrer\">Organisation of Islamic Cooperation<\/a> member countries.<\/p>\n<p>According to Netto, companies can also get information on government purchases. \u201cAnd it\u2019s a public procurement system that\u2019s coupled with investments. If a company invests in Saudi Arabia, the Health Ministry will buy its products for up to three years,\u201d he said.<\/p>\n<p>The diretor said four Brazilian pharma companies are currently selling product to Saudi Arabia. \u201cThe opportunity is there. If Brazilian companies fail to take up space, then companies from other countries will capture this market share,\u201d he said.<\/p>\n<p><strong>Quick facts <\/strong><\/p>\n<p>Brazil-Saudi Arabia Pharma Seminar<br \/>\nOctober 8<br \/>\n8:30am &#8211; reception<br \/>\n9am-11:30am \u2013 presentations<br \/>\n11:30am-2:30pm \u2013 one-on-one talks with companies<br \/>\nArab Brazilian Chamber of Commerce Auditorium<br \/>\nAvenida Paulista, 283, 11<sup>th<\/sup> floor, S\u00e3o Paulo, SP<br \/>\nRegister <a href=\"https:\/\/saudipharma.typeform.com\/to\/aYwl5q\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a><\/p>\n<p><strong>Translated by Gabriel Pomerancblum<\/strong><\/p>\n<div class=\"credits-overlay\" data-target=\".wp-image-259098\">Mateus Bonomi\/AGIF\/AFP<\/div>\n","protected":false},"excerpt":{"rendered":"<p>An Arab Brazilian Chamber of Commerce event will explore an industry that grows 5% per year and is deemed strategic by the Arab country\u2019s government, with an expected USD 71 billion in investment through 2020.<\/p>\n","protected":false},"author":2324,"featured_media":259098,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[107],"tags":[9534,11787,11718,11786,2838,9595],"class_list":{"0":"post-259226","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business-opportunities","8":"tag-brazil-en","9":"tag-brazil-saudi-arabia-pharma-seminar","10":"tag-farmacos","11":"tag-pharma","12":"tag-pharmaceuticals","13":"tag-saudi-arabia-en"},"wps_subtitle":"An Arab Brazilian Chamber of Commerce event will explore an industry that grows 5% per year and is deemed strategic by the Arab country\u2019s government, with an expected USD 71 billion in investment through 2020.","_links":{"self":[{"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/posts\/259226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/users\/2324"}],"replies":[{"embeddable":true,"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/comments?post=259226"}],"version-history":[{"count":0,"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/posts\/259226\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/media\/259098"}],"wp:attachment":[{"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/media?parent=259226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/categories?post=259226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/anba.com.br\/en\/wp-json\/wp\/v2\/tags?post=259226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}